Day: August 13, 2025

Conference call to follow tomorrow, August 14 at 5 PM EST NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company’s financial performance and outlook for 2025. “Yet another quarter of revenue growth in both company divisions, along with overall gross margin improvement, has led to an improved cash performance for the Company. With the remaining repayment of the Change Healthcare loan to be completed by the end of the year, and continued strength in both revenue and margin growth, management believes that the Company is on track to end the year as a cash flow positive business, and with a debt-free, strong balance sheet,” said Ilan Danieli, Precipio’s CEO. Q2-2025 Financial Results:Revenues....

Q1 Fiscal 2026 HighlightsRecord royalties of $4.0 million Record adjusted EBITDA1 of $3.3 million Total revenues of $13.0 million Net profit of $2.0 million after a $0.9 million restructuring chargeMONTREAL, Aug. 13, 2025 (GLOBE NEWSWIRE) — D-BOX Technologies Inc. (“D-BOX” or the “Company”) (TSX: DBO) today reported financial results for its first quarter ended June 30, 2025. “In Q1 2026, D-BOX delivered robust financial performance with record royalty growth and strong profitability,” said Naveen Prasad, interim CEO of D-BOX. “Following record revenues and net income performance for the full fiscal year 2025, the Company continues to demonstrate the strength of our royalty-focused model, expanded theatrical footprint and disciplined expense control.” Q1 2026 Operating Results In Q1 2026, total revenues were $13.0...

HighlightsNet revenue of $1.6 billion, an increase of 6.9% compared to Q2 2024 Adjusted EBITDA1 increase of 15.0% to $284.4 million and adjusted EBITDA margin1 of 17.8%, a 120 basis point increase over Q2 2024 Diluted EPS of $1.19 and adjusted EPS1 of $1.36, up 63.0% and 21.4%, respectively, compared to Q2 2024 Contract backlog of $7.9 billion, up 9.9% year-over-year, including 9% organic growth Acquired Cosgroves, a 90-person industry-leading firm, expanding buildings engineering capabilities in New Zealand Closed the acquisition of Page, a 1,400 person US-based design, architecture and engineering firm Increased guidance for net revenue, EBITDA margin, adjusted diluted EPS and adjusted ROIC to reflect strong performance year-to-date and the closure of the Page acquisition.EDMONTON, Alberta and NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE)...

TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) reported today its operational and financial results for the three and six months ended June 30, 2025. This press release should be read in conjunction with the Company’s Management Discussion and Analysis (“MD&A”) and interim consolidated financial statements for the six months ended June 30, 2025, which are available on the Company’s website and at www.sedarplus.ca. Highlights from the second quarter include1:On a continuing operations basis, Mattr delivered revenue of $321 million and operating income of $10 million. Adjusted EBITDA2 increased by 5% from prior year quarter to $42 million; The Connection Technologies segment’s second quarter revenue increased by 99% to $177 million compared to $89 million in the prior year’s...

Not for distribution to U.S. News wire services or dissemination in the U.S. VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) is pleased to announce its financial results for the three months ended June 30, 2025 (the “quarter”) and the six months ended June 30, 2025 (“YTD”). On May 5, 2025, the Fund entered into a non-binding letter of intent to which one or more affiliates of Fairfax Financial Holdings Limited (“Fairfax”) will acquire all of the issued and outstanding units of the Fund other than those already owned by Fairfax (including the Exchangeable Partnership units held by KRL), at a purchase price of $18.60 per unit, payable in cash. On June 17, 2025, the Fund entered into an arrangement agreement (the “Arrangement Agreement”) with 1543965 B.C. Ltd....

– CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD – Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT-SORD at PNS 2025 Annual Meeting highlighting slowed progression of disease observed via MRI at 24 months – Launched new sponsored Sorbitol Assay to support identification of patients suspected of having CMT-SORD – Entered into out-licensing agreement with Biossil, Inc. for AT-001 – New data on govorestat for the treatment of PMM2-CDG to be presented at the 2025 ASHG Annual Meeting – Ongoing review of govorestat development program for Classic Galactosemia progressing as planned NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Applied Therapeutics,...

~ Record Adjusted Gross Margin – 60.6%, up from 42.7% last quarter ~ ~ Strong Adjusted Gross Profit Growth – up 32.7% from last quarter and 71.6% Y/Y ~ ~ Year-over-Year Revenue Growth – $2.35M up 14.2% from Q3 2024 ~ IRVINE, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) — Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs” or the “Company”), a leading provider of advanced connectivity solutions, today announced financial results for its third fiscal quarter and nine months ended June 30, 2025. “Mobix Labs delivered one of its strongest quarters ever, achieving record adjusted gross margins, substantial gross profit growth, and a sharp improvement in operating results,” said Phil Sansone, CEO of Mobix Labs. “These results demonstrate the power of our focus on high-margin products, operational discipline, and deep customer relationships in driving...

MISSISSAUGA, Ontario, Aug. 13, 2025 (GLOBE NEWSWIRE) — “Bird continues to execute on its 2025-2027 Strategic Plan, focusing on sectors that have long-term demand drivers, and maintaining a risk balanced and highly collaborative work program that will drive growth and continued margin accretion. Even though the Company’s second quarter was impacted by temporary project delays as our clients adapted to rapidly changing market conditions, these same clients awarded us additional scopes and work packages, giving us confidence that the work programs will proceed in the future once there is greater clarity on cost and economic conditions,” stated Teri McKibbon, President and CEO of Bird Construction. “While Bird’s third quarter is expected to be impacted by similar delays, the Company is well positioned to capitalize on our record $4.6...